Since the early 1980s, when the disease first reached the public consciousness, the prevalence of HIV in women has risen dramatically. An estimated 18 million women live with HIV today, representing more than half of the world's HIV-positive adults. 25 percent of people who are HIV-positive are women in the United States. A university research team has quantified the impact of human immunodeficiency virus (HIV) infection on the growth of cervical cancer. Their findings indicate that in women who are HIV infected, the risk of developing cervical cancer is six times higher. Especially affected is Southern and Eastern Africa. Early studies indicated that HIV-positive women had a lower risk than HIV-negative women for cervical cancer. However, multiple studies have also reported that women who are HIV-positive are substantially more likely to develop cervical cancer. Most cases of invasive cervical cancer are preventable, almost all of which are caused by the human papillomavirus (HPV). Cervical cancer, on the other hand, is also one of the most successfully preventable and treatable forms of cancer, typically caused by human papillomavirus (HPV), provided that it is diagnosed early and treated effectively. Around the same time, cervical cancer is the most often diagnosed cancer in women living with HIV, as HIV infection weakens their immune systems. The risk of chronic HPV infection, which often progresses to cervical cancer, is increased for women with HIV. In LMICs, the burden of HPV in HIV-positive women is extremely high. Women with HIV should be warned of their increased risk of HPV and cervical cancer and recommended to be vaccinated against HPV if possible. They should also be tested for HPV regularly, beginning at the time of the diagnosis of HIV. The main aim of our journal (Journal of HIV and AIDS Research) is to draws readers' attention to the latest advances in HIV research in the fields of prevention, care and cure. The peoples who are interested to publish their article they can submit their manuscripts in our journal through given link: https://www.scholarscentral.org/submissions/hiv-aids-research.html

Ella Addison

Managing Editor

Journal of HIV and AIDS Research

Mail ID: aids@emedicaljournals.org

WhatsApp no: + 1-504-608-2390